These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28126259)

  • 1. Screening test recommendations for methicillin-resistant Staphylococcus aureus surveillance practices: A cost-minimization analysis.
    Whittington MD; Curtis DJ; Atherly AJ; Bradley CJ; Lindrooth RC; Campbell JD
    Am J Infect Control; 2017 Jul; 45(7):704-708. PubMed ID: 28126259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for methicillin-resistant Staphylococcus aureus carriage by polymerase chain reaction on the duration of unnecessary preemptive contact isolation.
    Uçkay I; Sax H; Iten A; Camus V; Renzi G; Schrenzel J; Perrier A; Pittet D
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1077-9. PubMed ID: 18844467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, patient experience and cost impacts of performing active surveillance on known methicillin-resistant Staphylococcus aureus positive patients admitted to medical-surgical units.
    Goldsack JC; DeRitter C; Power M; Spencer A; Taylor CL; Kim SF; Kirk R; Drees M
    Am J Infect Control; 2014 Oct; 42(10):1039-43. PubMed ID: 25278390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid diagnostic testing of methicillin-resistant Staphylococcus aureus carriage at different anatomical sites: costs and benefits of less extensive screening regimens.
    Wassenberg MW; Kluytmans JA; Bosboom RW; Buiting AG; van Elzakker EP; Melchers WJ; Thijsen SF; Troelstra A; Vandenbroucke-Grauls CM; Visser CE; Voss A; Wolffs PF; Wulf MW; van Zwet AA; de Wit GA; Bonten MJ
    Clin Microbiol Infect; 2011 Nov; 17(11):1704-10. PubMed ID: 21595786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects.
    Wassenberg MW; Kluytmans JA; Box AT; Bosboom RW; Buiting AG; van Elzakker EP; Melchers WJ; van Rijen MM; Thijsen SF; Troelstra A; Vandenbroucke-Grauls CM; Visser CE; Voss A; Wolffs PF; Wulf MW; van Zwet AA; de Wit GA; Bonten MJ
    Clin Microbiol Infect; 2010 Dec; 16(12):1754-61. PubMed ID: 20219077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for Methicillin-Resistant Staphylococcus aureus Prevention in Adult ICUs: A Cost-Effectiveness Analysis.
    Whittington MD; Atherly AJ; Curtis DJ; Lindrooth RC; Bradley CJ; Campbell JD
    Crit Care Med; 2017 Aug; 45(8):1304-1310. PubMed ID: 28471887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal rapid screening for methicillin-resistant Staphylococcus aureus in the intensive care units in a large community hospital.
    Kjonegaard R; Fields W; Peddecord KM
    Am J Infect Control; 2013 Jan; 41(1):45-50. PubMed ID: 22651895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of supplementing a broth-enriched culture test with the Xpert meticillin-resistant Staphylococcus aureus (MRSA) assay for screening inpatients at high risk of MRSA.
    Li J; Ulvin K; Biboh H; Kristiansen IS
    J Hosp Infect; 2012 Dec; 82(4):227-33. PubMed ID: 23098683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of universal MRSA screening on admission to surgery.
    Murthy A; De Angelis G; Pittet D; Schrenzel J; Uckay I; Harbarth S
    Clin Microbiol Infect; 2010 Dec; 16(12):1747-53. PubMed ID: 20331684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymerase chain reaction screening for methicillin-resistant Staphylococcus aureus and contact isolation.
    Spence MR; Courser S; Dammel T
    Am J Infect Control; 2009 Sep; 37(7):601-2. PubMed ID: 19181426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of screening intensive care unit patients for methicillin-resistant Staphylococcus aureus in hospitals.
    Nyman JA; Lees CH; Bockstedt LA; Filice GA; Lexau C; Lesher LJ; Como-Sabetti K; Lynfield R
    Am J Infect Control; 2011 Feb; 39(1):27-34. PubMed ID: 21281884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for methicillin-resistant Staphylococcus aureus: a comparative effectiveness review.
    Glick SB; Samson DJ; Huang ES; Vats V; Aronson N; Weber SG
    Am J Infect Control; 2014 Feb; 42(2):148-55. PubMed ID: 24360519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid MRSA test in exposed persons: costs and savings in hospitals.
    Andersen BM; Tollefsen T; Seljordslia B; Hochlin K; Syversen G; Jonassen TØ; Rasch M; Sandvik L
    J Infect; 2010 Apr; 60(4):293-9. PubMed ID: 20122959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin-resistant Staphylococcus aureus prevention strategies in the ICU: a clinical decision analysis*.
    Ziakas PD; Zacharioudakis IM; Zervou FN; Mylonakis E
    Crit Care Med; 2015 Feb; 43(2):382-93. PubMed ID: 25377019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal swabs collected routinely to screen for colonization by methicillin-resistant Staphylococcus aureus in intensive care units are a sensitive screening test for the organism in clinical cultures.
    Byrnes MC; Adegboyega T; Riggle A; Chipman J; Beilman G; Reicks P; Boeser K; Irwin E
    Surg Infect (Larchmt); 2010 Dec; 11(6):511-5. PubMed ID: 20969468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study.
    Reilly JS; Stewart S; Christie P; Allardice GM; Stari T; Matheson A; Masterton R; Gould IM; Williams C
    J Hosp Infect; 2012 Jan; 80(1):31-5. PubMed ID: 22104473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and effects of different admission screening strategies to control the spread of methicillin-resistant Staphylococcus aureus.
    Gurieva T; Bootsma MC; Bonten MJ
    PLoS Comput Biol; 2013; 9(2):e1002874. PubMed ID: 23436984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers.
    McKinnell JA; Bartsch SM; Lee BY; Huang SS; Miller LG
    Infect Control Hosp Epidemiol; 2015 Jan; 36(1):2-13. PubMed ID: 25627755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA).
    Harbarth S; Hawkey PM; Tenover F; Stefani S; Pantosti A; Struelens MJ
    Int J Antimicrob Agents; 2011 Feb; 37(2):110-7. PubMed ID: 21163628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of a three-year meticillin-resistant Staphylococcus aureus screening programme.
    Collins J; Raza M; Ford M; Hall L; Brydon S; Gould FK
    J Hosp Infect; 2011 Jun; 78(2):81-5. PubMed ID: 21507518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.